Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp.
- Market cap
- $20.84K
Your view on KTTAW
Overview
What the company does, where it operates, and who runs it.
About Pasithea Therapeutics Corp.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Tiago Reis Marques
- Headquarters
- 1111 Lincoln Road, Miami Beach, FL, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Tiago Reis Marques
- Headquarters
- 1111 Lincoln Road, Miami Beach, FL, US
Pasithea Therapeutics Corp. is a biotechnology firm dedicated to exploring and developing therapies for various psychiatric and neurological conditions. Beyond its research endeavors, the company intends to establish clinics specializing in the treatment of depression.
At these facilities, certified pharmacists will administer intravenous ketamine infusions, and the firm will also extend business support services for these operations. Founded in 2020, Pasithea Therapeutics Corp. maintains its corporate headquarters in Miami Beach, Florida.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Pasithea Therapeutics Corp.. Starting points for Pasithea Therapeutics Corp.: EPS -$440.92, beta 0.29 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Pasithea Therapeutics Corp.. Trailing twelve-month EPS for Pasithea Therapeutics Corp. stands at -$440.92. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Pasithea Therapeutics Corp.. Pasithea Therapeutics Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BXPHFBotanix Pharmaceuticals Limited | Healthcare | OTC | $89.0M | ||
| ARUXFAcrux Limited | Healthcare | OTC | $1.8M | ||
| ARVNArvinas, Inc. | Healthcare | NASDAQ | $423.0M | ||
| ARWRArrowhead Pharmaceuticals, Inc. | Healthcare | NASDAQ | $5.8B | ||
| ASBPAspire Biopharma Holdings, Inc. | Healthcare | NASDAQ | $822,602 | ||
| ASBPWAspire Biopharma Holdings, Inc. | Healthcare | NASDAQ | $121,920 | ||
| ASCLFAscletis Pharma Inc. | Healthcare | OTC | $2.1B | ||
| ASEP.CNAsep Medical Holdings Inc | Healthcare | CNQ | — | ||
| ASMBAssembly Biosciences, Inc. | Healthcare | NASDAQ | $454.4M | ||
| ASNDAscendis Pharma A/S | Healthcare | NASDAQ | $16.6B | ||
| ASPEAspen Neuroscience Inc. | Healthcare | NASDAQ | $361.2M | ||
| ASPHFAscentage Pharma Group International | Healthcare | OTC | $3.2B | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Pasithea Therapeutics Corp., and how their positions are changing. At a $20,838 market value, institutional positions materially move Pasithea Therapeutics Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Pasithea Therapeutics Corp. executives and directors. Shares of Pasithea Therapeutics Corp. have traded between $0.0021 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Pasithea Therapeutics Corp.. Coverage tracks Pasithea Therapeutics Corp. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Pasithea Therapeutics Corp.